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 Abstract: 
Testing of a culture protocol for converting mouse embryonic stem cells 
into neurons  
 
Embryonic stem cells (ESCs) are pluripotent cells that are present in the inner 
cell mass of blastocyst-stage embryos. They are pluripotent in that they are 
able to differentiate into all derivatives of the primary germ layers, including 
ectoderm, mesoderm, and endoderm, thus generating every cell type in the 
body. Directed differentiation of ESCs into the cell line of interest can help 
to replace cells lost due to injury or disease.  
The objective of this study was to culture mouse embryonic stem cells with 
retinoic acid to achieve neuronal differentiation and to confirm neural 
conversion using immunocytochemistry. 
This protocol, referred to as the 4-/4+ protocol, involves spontaneous 
differentiation of mESCs into embryoid bodies in suspension culture for 4 days 
and addition of 0.5 µM RA on the 4th day. The cells were allowed to aggregate 
in the presence of RA for another four days and then plated on laminin-coated 
dishes on the 8th day. They were plated both as intact aggregates and post-
disassociation with trypsin. In both cases, it was found that they gave out flat 
cells tightly adherent to the surface with an initial spindle shaped bipolar 
morphology that gradually progressed to pyramidal shaped cells with multiple 
 neurites. . Immunocytochemistry was used to confirm the presence of neurons 
by using a neuron specific isoform of monoclonal βIII-Tubulin. 
The results indicate that mouse embryonic stem cells in the presence of 
retinoic acid differentiate into cells that phenotypically resemble neurons. 
These cells express the neuronal marker, βIII-Tubulin , confirming that 
they are neurons.  
 
 
 
 
Keywords:   Mouse embryonic stem cells (mESCs), Retinoic Acid (RA), 
differentiation, culture, neurons, βIII-Tubulin. 
 
 
 
 
 
  
Introduction 
 
One of the tools that regenerative medicine has, as of today, is the ability to 
induce a particular type of cell from an unbiased, naïve cell. The ability of this 
naïve cell to form any cell of the germ layer – known as Pluripotency – and in 
effect, any tissue of the organism, gives us the potential to repair any tissue 
that is damaged and restore any function that is lost. 
Embryonic stem cells, henceforth referred to as ESCs, are the pluripotent cells 
residing in the inner cell mass of the blastocyst stage of the embryo. They 
possess a normal karyotype , maintain a high telomerase activity and exhibit 
the potential for indefinite proliferation. Directed differentiation of these cells 
offers us the opportunity to create tissue of any organ system, to study them in 
vitro, and to therapeutically replace cells that have been lost or damaged.  
Unlocking this potential with elimination of adverse events is the all-
consuming quest of tissue engineering at this time. The dream to grow the 
tissue we need in plates and replace si opus sit is not only perceived as tangible 
but also assumed as the next logical step. Perfecting the methods of induction 
and maintenance of the culture of ESCs, differentiated into the cell line of 
choice, is key to creating a reliable, steady supply of tissue.  
 The objective of this dissertation is to test one such protocol; of conversion of 
mouse ESCs into neurons. 
 
 
 
 
 
 
 
 
  
 Aims 
 
To establish culture protocols to differentiate mouse embryonic stem cells into 
neurons. 
 
Objectives 
1. To culture mouse embryonic stem cells with retinoic acid to achieve neuronal 
differentiation. 
2. To confirm neural conversion using immunocytochemistry. 
 
 
 
 
 
 
 Literature Review 
 
Embryonic Stem Cells 
Embryonic stem cells have two properties that make them an extremely useful 
tool to study development: pluripotency and the ability of self-renewal.  
The study of pluripotency began with the discovery of the strain of mice that 
developed teratocarcinoma spontaneously. These multi-differentiated tumours 
contain derivatives of all germ layers and an undifferentiated proliferative 
compartment. It was shown that the primitive proliferative cells called 
embryonal carcinoma cells could be maintained in culture and they maintained 
their pluripotency. However, embryonal carcinoma cells are tumorigenic and 
karyotypically abnormal. This subsequently led to the derivation of pluripotent 
stem cells from pre-implantation mouse embryos. These embryonic stem cells 
were not tumorigenic and were genetically normal (1). 
Embryonic stem cells help to understand lineage segregation in early embryo 
and hence serve as a model to understand development. Since they are 
pluripotent, embryonic stem cells have been used widely to study development 
through gene targeting.  Embryonic stem cells are also being used as powerful 
biological models of disease. This is important to understand disease 
progression and also to identify and test novel pharmacological  interventions. 
 They also serve as a potential source of cells for replacement after disease or 
injury.  
 Embryonic stem cells are isolated from blastocyst of preimplantation embryo 
(2). Embryonic stem cells were initially derived by culturing them with feeder 
layer in a medium containing serum. This feeder layer comprised of mitotically 
inactivated fibroblasts. Later, it was found that feeder layer was not mandatory 
and could be replaced by a cytokine, Leukaemia Inhibitory Factor (LIF) (3), 
and that serum could be replaced by Bone Morphogenetic Protein (BMP) (4). 
The balance between differentiation and self-renewal of embryonic stem cells 
is controlled by signaling pathways and a complex network of genes. 
Maintenance of pluripotency in mouse embryonic stem cells is dependent on 
the activation of gp130 receptor subunit which is normally achieved in the 
culture medium by the addition of IL-6 family of cytokines. Leukemia 
Inhibitory Factor (LIF), an IL-6 class cytokine, maintains the self-renewal of 
the ESCs (3,5,6). It inhibits  differentiation and supports proliferation of 
undifferentiated stem cells. It mediates this action via heterodimerization of the 
low-affinity receptor (LIF-R) and gp130, members of class I cytokine 
receptors.  
Several protocols have been established to drive embryonic stem cells into 
differentiation towards different lineages of cells. Some authors broadly 
classify differentiation protocols as direct and indirect. Both categories of 
 protocols require the removal of the influence of pluripotency dependent 
factors and differ only in the presence and absence of added signals. Indirect 
differentiation, also known as spontaneous differentiation, does not require any 
additional signals,  and allows the formation of embryoid bodies. 
Notwithstanding this classification, three methods have been described to 
initiate ESC differentiation. In the first method, ESCs are allowed to aggregate 
and form three-dimensional colonies known as Embryoid bodies (EBs) (7). In 
the second method, ESCs are cultured on stromal cells (8). The third method 
involves differentiation in a monolayer on extracellular matrix proteins (9). 
Our focus in this dissertation will be on taking the EB route. 
 
 
Embryoid Bodies 
Embryoid bodies are three-dimensional aggregates containing cells of the 
primary germ layers (10). Each embryoid body contains partially differentiated 
ESCs and a cavity due to cell death. The various approaches for the 
differentiation of ESCs via the formation of embryoid bodies include: 
a) Culture of ESCs in suspension without LIF, allowing spontaneous 
differentiation of embryoid bodies in a non-treated dish. 
 b) Directed differentiation of embryoid bodies into specific cell lineages 
by the addition of growth factors. 
Due to the similarities between embryoid bodies and pre-gastrulation embryo, 
the method of spontaneous differentiation is preferred and extensively used. 
At the initial step of embryoid body formation, to generate embryoid bodies of 
good quality, it is crucial to use the right density of ESCs. The size, shape and 
morphology of embryoid bodies can be used to judge the quality of embryoid 
bodies during spontaneous differentiation (11). 
It has been found that the size of embryoid bodies influences the lineage of 
differentiation (11,12). Endothelial cell differentiation was found to be 
enhanced in smaller embryoid bodies (150-300 µm in diameter), whereas 
embryoid bodies with a larger diameter of around 450µm promoted 
cardiogenesis (13).  
Several protocols have been established to control the shape and size of 
embryoid bodies (10). They include: 
a) Suspension culture in a Petri dish 
b) Hanging drop method 
c) Microwell/microcapsule method  
 
 
 Suspension Culture 
The suspension culture in a Petri dish is the simplest method to generate 
embryoid bodies. The ESCs, harvested from the feeder layer, are counted and 
suspended in a non-treated Petri dish, thereby allowing them to aggregate and 
form embryoid bodies. This method allows us to generate a large number of 
embryoid bodies in a Petri dish but the shape and size cannot be controlled. It 
is crucial to use only a non-coated Petri dish and not a coated one as the latter 
will promote adhesion to the dish and not allow cell-to-cell attachment.  
Hanging Drop Method 
Embryoid bodies, homogenous in size, are generated by suspending ESCs in 
drops hanging on the cover of the Petri dish. The hanging drop creates an area 
clear off the surface of the dish, allowing for the ESCs to organize into EBs. 
However, this method limits our yield per plate and makes the changing of 
medium extremely challenging (14). 
Microwell/microcapsule method 
The microwell method uses a non-coated, round-bottomed, 96-well plate to 
generate the EBs. The round-bottom reduces the chances of adhesion to plate 
and allows us to control the size and shape of the EBs formed. Initial cell 
density dictates the final size of the EBs; a size between 100 to 500 µm can be 
 achieved. Unlike the hanging drop method, changing the medium is not 
challenging. 
 
Neural Differentiation in Embryoid Bodies 
Neural cells represent only a small fraction of cells in embryoid bodies when 
cultured with fetal bovine serum (FBS). Hence, we need to nudge the EBs into 
yielding a higher percentage of neural cells. Several different protocols have 
been described to achieve the neural differentiation of embryonic stem cells. 
The various approaches include: 
1. Treating serum-stimulated EBs with retinoic acid (RA) (2). 
2. Repeatedly culturing EBs in serum followed by serum-free medium 
(15). 
3. Differentiating  ESCs as a monolayer in serum-free medium (16,17). 
4. Directly plating on stromal cells in serum-free medium (18,19). 
5. Creating a low-cell-density neurosphere culture (neural stem cell 
culture) with growth factors (16). 
 
 
4-/4+ protocol 
The 4-/4+ protocol is widely used in the differentiation of ESCs into neurons 
through the formation of embryoid bodies. Here, spontaneous differentiation of 
embryoid bodies is allowed during the first four days of culture. The mature 
 embryoid bodies formed this way are then exposed to all-trans retinoic acid 
(RA) for the next four days to induce differentiation towards neural lineage 
(2). A previous study showed that neural precursor cells appeared in day 6 
embryoid bodies and this population of neural precursor cells peaked around 
day 8 (20). 
Besides the RA 4-/4+ protocol, some other factors and cell signaling proteins 
can be used to trigger neural differentiation of embryoid bodies. Cell signaling 
pathways like FGF, BMP, Sonic hedgehog( SHH) and Wnts could be used for 
neural differentiation. 
Some studies have also shown neural differentiation of ESCs when cultured in 
a serum-free, feeder free layer in the absence of embryoid body formation. In 
this method, a primitive neural stem cell was identified displaying properties 
that were intermediate to ESCs and forebrain neural stem cells. This method 
can also be used as a conduit for the discovery of genes that regulate the 
transition of an ESC to a neural cell as it does not include the addition of any 
external factors (16). 
Growing ES cells in an adherent monoculture in the presence of FGF has also 
shown to generate neural precursors (17). 
 
 
 Signaling Pathways 
The moulding of an undifferentiated mass into a specific cell line will require a 
set of instructions for ESCs in the form of signals. Factors used to maintain 
undifferentiated status of ESCs, like LIF, have to be removed for the formation 
of embryoid bodies. LIF/Stat3 signaling pathway has been found to be one of 
the main LIF pathways regulating pluripotency of mESCs. The Wnt signaling 
pathway regulates self-renewal and differentiation of ESCs. It is also crucial 
for the development of central nervous system (10).  
Certain cell surface proteins called adhesion factors regulate cell-cell adhesion 
of ESCs. These molecules play an important role in aggregation and 
differentiation of ESCs. E-cadherin, a cell-cell adhesion factor regulates 
aggregation of mESCs and hESCs. Studies have shown that β-catenin could act 
as cell-cell adhesion factor in the formation of embryoid bodies (21).  The 
presence of a cell-cell adhesion defect has been found to increase the 
proportion of single cells, thereby decreasing the size of embryoid bodies and 
increasing cell death. Thus, cell adhesion factors are essential for survival and 
differentiation of ESCs. 
Series of events that lead to lineage commitment in vivo are observed in 
culture strategies. For instance, various studies have shown that exposure to 
Noggin facilitates neural differentiation. Noggin acts by inhibiting bone 
 morphogenetic protein (BMP) signaling which is known to block neural 
differentiation of ESCs in vitro (19,17). 
During development of mammalian central nervous system, differentiation 
properties of ESCs vary depending on their location and on the stage in which 
they are generated. Depending on the location, the differentiation is regulated 
by signals that modulate rostrocaudal or dorsoventral axis of the body. Based 
on this, several studies have tried to generate specific types of neurons and 
neural progenitors from ESCs by addition of these specific factors that serve as 
inductive signals such as FGF8 and Shh for dopaminergic neurons (17,18), 
SDIA and BMPs for dorsal and neural-crest derived cells, RA and Shh for 
motor neurons. 
 
 
Retinoic Acid 
RA is a metabolite of Vitamin A (retinol) that plays an important role in cell 
differentiation, growth and organogenesis. Conversion of retinol to retinoic 
acid requires two enzymatic reactions. The retinol is initially oxidized into 
retinal which is then converted to RA.  
It has been found that RA has two important roles in the development of the 
nervous system: neuronal differentiation and patterning (23). 
 As a patterning factor, RA plays a role in anteroposterior and dorsoventral 
patterning of neural tube and neural plate. In the anteroposterior axis of neural 
plate, RA with WNTs and fibroblast growth factors (FGFs), is responsible for 
organization of posterior hindbrain and anterior spinal cord (23). RA also 
controls dorsoventral axis formation. To show this effect of RA, the expression 
of class I genes  ( dbx1, dbx2, pax6, pax7, irx3 whose expression is repressed 
during early CNS development by Shh) and class II genes ( nkx6.1, nkx2.2, 
nkx6.2, olig2 - Shh activates their expression) was investigated in a study.  A 
previous study has shown that these genes were differentially expressed on the 
dorsoventral axis in progenitor domains of the developing hindbrain and spinal 
cord. Embryoid bodies treated with low-RA were found to express both class I 
and class II genes, indicating that they comprised of various populations 
throughout the dorsal to ventral neural tube whereas treatment with high-RA 
increased the expression levels of class I genes and reduced those of class II 
genes. Thus, showing that high levels of RA causes dorsalization of neural 
progenitor cells in embryoid bodies. 
As a factor facilitating neuronal differentiation, RA binds to the receptor 
complex comprising retinoic acid receptors (RARs) and retinoid X receptors 
(RXRs) in the nucleus and causes the transcription of target genes like Hox 
genes, Cdx1, RARs and HNF-3α. RA promotes the differentiation of different 
types of neurons and glia. Studies have suggested that RA promotes neuronal 
differentiation by the induction of many genes including those that encode cell 
 signaling molecules, enzymes, transcription factors, structural proteins and 
cell-surface receptors. Some of these are the transcription factor BRN2, SOX1, 
neurogenin1, nuclear factor κB( NFκB), STRA13 and SOX6; the extracellular 
molecule thrombospondin; cytoplasmic signaling molecules like protein kinase 
Cε, presenilin 1(PSEN1), microtubule-associated protein 1 (MAP2) and 
ceramide and components of the WNT pathway. Some genes need to be 
repressed for differentiation to occur such as SHP-1 and WNT inhibitor 
Dickkopf homologue 1(DKK1) (23).  
Down-regulation of Wnt signaling is another mechanism implicated in RA 
induced neural differentiation of ES cells (24). β-catenin, a key molecule in 
Wnt signaling, was shown to interact with RAR in a retinoid-dependent 
manner, thereby showing that retinoids cause a decrease in β-catenin-Lef/ Tcf-
mediated transactivation in a dose-dependent manner. Wnt3a signaling through 
Lef/Tcf1 has been known to suppress neural differentiation and induce 
mesodermal differentiation in mouse embryo (25). These findings suggest that 
RA acts by inhibition of Wnt-β-catenin anti-neural pathway by the 
upregulation of Secreted frizzled related protein 2(Sfrp2) (24) and 
sequestration of β catenin, thereby promoting neural differentiation. 
In addition to retinoic acid, FGF is another family of molecules involved in 
neurogenesis and is related to RA signaling. It has been shown that RA 
 promotes neural differentiation by the repression of FGF signaling from 
posterior neural plate (26).  
Effect of concentration of RA on ESC differentiation 
The effect of RA towards differentiation of a particular cell lineage depends on 
its concentration in the medium. Cultures that are exposed to low 
concentrations of RA (10-9 M ) have abundant cardiac muscle. Skeletal muscle 
is found in abundance at higher concentrations of 10
-8
 M (19). 500 nM RA 
supplementation has been reported to induce neuronal differentiation (27). 
Concentrations above 1500 nM causes death of embryonic cells. Higher 
concentrations also promote faster differentiation as shown by the pattern of 
expression of Oct3/4 which got down-regulated more rapidly in embryoid 
bodies that were exposed to higher concentrations of RA. It was also shown 
that concentration of RA determines the terminal differentiation of neurons 
derived from ES cells. βIII-Tubulin and GFAP, markers of differentiated 
neurons and glia respectively, was greater in embryoid bodies that were treated 
with higher concentrations of RA. On the other hand, expression of markers of 
undifferentiated neural cells, i.e , Group B Sox, Nestin, Olig2, and sox1 
mRNA was higher with low concentrations of RA.  
The ability of RA to promote neuronal differentiation can be utilized to 
produce neural cell types that can be used in therapeutic transplantation. 
Haematopoietic stem cells, embryonic stem cells, and neural stem cells can be 
 used for neuronal differentiation using combinations of retinoic acid and 
growth factors. When some of these combinations were used in vivo to test 
their ability to replace lost neurons, they were found to survive and 
differentiate into neurons or glia on grafting them in different locations in the 
adult brain; including as treatment for Huntington's disease (28) and stroke 
(29). Neurons produced this way form functional synapses, acquire dendritic 
and axonal polarity, include a mixture of excitatory and inhibitory cells that 
release glutamate and GABA or glycine respectively (30).  
Similar to other developmental molecules, RA plays a role even after 
development. Elevated signaling of RA has proven to trigger axonal outgrowth 
and hence nerve regeneration. RA also takes part in the maintenance of adult 
neurons. Disruption of RA signaling could lead to degeneration of motor 
neurons leading to motor neuron disease, development of Alzheimer's disease 
and Parkinson's disease (23).  
 
Cell Culture 
Cell culture is an invaluable technique for researchers in numerous fields. It 
facilitates the study of biological processes and properties that are not 
accessible at the level of an intact organism.  
There are four basic requirements for efficient cell culture. These are: 
 a) Properly equipped cell culture facility. 
b) Sterile technique. 
c) Reagents and supplies. 
d) Knowledge and practice of fundamental techniques involved in the 
growth of cell type of interest. 
Cell culture facility 
The basic requirement for successful cell culture is an established and well-
equipped cell culture facility. This includes the biosafety cabinet, centrifuge, 
refrigerator, microscope( for examination of cell cultures and for counting 
cells), a humidified incubator that is set at 37ᵒC with 5% CO2. 
A biosafety cabinet (BSC) is a ventilated  laboratory workspace to work safely 
with  contaminated materials requiring biosafety. It was first available 
commercially in 1950. There are different types of biosafety cabinets, 
depending on the degree of biocontainment required.  
The main purpose of a biosafety cabinet is to protect the researcher and 
surrounding environment from pathogens. The exhaust air is HEPA-filtered 
(High efficiency particulate air filter) when it leaves the biosafety cabinet, 
removing harmful viruses and bacteria. Most biosafety cabinets also serve the 
secondary purpose of maintaining sterility of materials placed inside. 
 Biosafety cabinets are classified into three types by the U.S. Centers for 
Disease Control and Prevention. These different classes are categorized based 
on two aspects: level of personnel and environmental protection and level of 
product protection provided. 
Class I cabinets: They provide personnel, environmental protection but not 
product protection. The inward flow of air can in fact cause contamination of 
samples. They are used to enclose some equipment like centrifuges or 
procedures (like aerating cultures). 
Class II cabinets: They provide both personnel, environmental and product 
protection. They are of five types: Type A1, Type A2, Type B1, Type B2 and 
Type C1. Type A2 cabinets are the most commonly used biosafety cabinets. 
The principle of operation involves use of motor driven fans in the cabinet that 
draw mass airflow around the user into the air grille, thus protecting the 
operator. The air then goes underneath the work surface and back to top of the 
cabinet wherein it passes through HEPA filters. A column of sterile air that is 
HEPA filtered also blows downwards, over products to prevent contamination. 
Air exhaust also happens through a HEPA filter and depending on type of 
Class II biosafety cabinet, it is either re-circulated back to the laboratory or 
pulled in by an exhaust fan where it is expelled from the building. 
The Type A1 cabinet has minimum inflow velocity of 75ft/ min. The 
downflow air (contaminated) splits above the work surface and mixes with 
 inflow. The air is drawn up through the back of the cabinet and then blown into 
a positive pressure . Then the air is either re-circulated back down over the 
work area or pulled in through exhaust out of the cabinet (both through a 
HEPA filter).  
The Type A2 cabinet has minimum inflow velocity of 100 ft/min. Here, all 
contaminated positive pressure plenums are surrounded by a negative air 
pressure plenum. It is identical to Type A1 cabinet with respect to all other 
specifications. 
Type B1 and B2 cabinets have minimum inflow velocity of 100 ft/min. In 
contrast to Type A cabinets, Type B biosafety cabinets use single pass airflow, 
i.e, the air does not mix and recirculate. This is to ensure control of hazardous 
chemical vapours.  
Type C1 cabinet was designed to control infectious material and chemical 
hazards. Here, movement of air occurs by mixing of inflow air with air in the 
column of downflow air. These cabinets, like Type B, use single pass airflow. 
Class II cabinets are the most commonly used biosafety cabinets in research 
and clinical laboratories. 
Class III cabinets: Mostly installed in maximum containment laboratories. 
They are specially designed to work with BSL-4 pathogenic agents to provide 
maximum protection.  
 A humidified CO2 incubator is an equipment that is invaluable for cell culture. 
The goal of placing cells in a CO2 incubator set at 37ᵒC is to provide the cells 
their native temperature for them to survive and thrive. All parameters are 
important. Proper temperature, humidity and gas tension work together to 
provide optimum growth of cells. CO2 gas is used to maintain in vivo pH to 
mimic CO2 tension in the bloodstream. When pH varies from neutral, cells 
tend to stop growing and then lose viability. Improper pH could produce 
morphological changes such as vacuoles in cytoplasm or granules around 
nucleus. High humidity serves to prevent evaporation of growth media. 
Humidity of around 85-95% helps to limit evaporation of growth media. 
Evaporation of water from the growth media leads to a high concentration of 
salts, minerals which lead to toxicity and cell death. All these parameters work 
together to maintain healthy cells that express accurate protein profiles. Proper 
culturing is highly essential for sensitive primary and stem cells. 
 
Practice of Sterile Technique 
The practice of sterile technique is a highly essential prerequisite for 
maintenance of healthy, infection-free cells. Prior to beginning of the work, the 
biosafety cabinet must be turned on and allowed to run for a minimum of 
fifteen minutes in order to purge the contaminated air. The work surface within 
the cabinet must be decontaminated with an appropriate solution. Generally, 
 70% ethanol or isopropanol are used for this purpose. Any other materials for 
the procedure must be similarly decontaminated before placing inside the 
biosafety cabinet. This is of paramount importance if solutions or media have 
been warmed in a water bath before use. The person must don appropriate 
personnel equipment for that particular cell type. Ideally, this should consist of 
lab coat with cuffs of the sleeves secured to prevent transfer of biological 
contaminants and vinyl or latex gloves that should cover all exposed skin 
entering the biosafety cabinet. Gloved hands must be sprayed with 
decontaminant before putting them into the cabinet. Gloves must be changed if 
something outside the cabinet is touched. Care must be taken to ensure the 
sterility of everything coming in contact with cells or reagents. 
Reagents and Supplies 
Tissue culture requires the use of media containing all the adequate nutrients 
for the cells to survive. There are many suppliers of tissue culture media and 
supplements. All media and reagents used must be tissue-culture grade. The 
culture dishes and flasks that are used must be sterile.  
Finally, it is important to have sound knowledge of the techniques required to 
culture the cell line of interest. Each cell line has its own prerequisite 
conditions and this must be known to the researcher. 
Prior to beginning any cell culture work, it is essential to check that all the 
equipment is in optimal working condition. Some of the things to be checked 
 are: temperature and CO2 levels in the incubator, should be ensured that water 
pan in the incubator is filled with clean water and that it contains copper 
sulfate in order to inhibit bacterial growth.  
 
 
 
Immunocytochemistry 
Immunocytochemistry is a technique used to define 'cellular location of 
biochemically defined antigens'. Immunocytochemistry began in 1942 when 
Albert Coons reported localization of pneumococcal antigens in liver sections 
by using a fluorescent-labeled antibody. It is a blend of immunochemistry and 
morphology. On one hand, biochemistry and immunochemistry use specific 
tools such as antibodies or high-affinity markers and on the other hand, 
microscopy determines if the target molecule is associated with any organelle, 
cell or tissue. 
Immunocytochemistry is an invaluable tool used to anatomically visualize the 
location of a specific protein or antigen in the cells by using a specific primary 
antibody that binds to the antigen. The primary antibody facilitates 
visualization of the protein by a fluorescence microscope when the primary 
antibody is bound by a secondary antibody that has conjugated fluorophore. 
 This technique helps to evaluate if cells in a sample express that particular 
antigen.  
In contrast to immunohistochemistry, where samples are sections of biological 
tissues, immunocytochemistry is performed on intact cells. The cells could be 
from samples grown in culture or cell suspensions.   
Historically, many approaches existed for detection of antigens at the level of 
light microscope as well as electron microscope for the localization of cell 
surface molecules. But these methods were not very efficient in ultrastructural 
localization of intracellular antigens. This was largely because of the use of 
various reagents in these methods that caused extensive destruction of cell 
structure.  In an attempt to preserve the fine structural details for 
immunocytochemistry, epoxy resins were used as done for routine 
ultrastructural studies. This too did not provide much success as a large 
fraction of antigens did not recognize antibodies. Historically, two approaches 
were suggested to tackle this problem. The first was to find an alternative 
embedding media to epoxy resin, one that would be water-soluble and would 
facilitate labeling of thin sections. The second approach involved pre-
embedding techniques wherein antibodies were introduced into cells (detergent 
permeabilized) prior to embedding. The idea here was to make small holes in 
the cell membrane (using solvents and detergents) just large enough to let 
antibody penetrate the cell without damaging fine-structural details. Another 
 technique, called post-embedding labeling where labeling was done on 
sections, was not very efficient due to technical difficulties. This was followed 
by the development of a technique by Farrant and Mclean in the 1970s called 
the cross- linked bovine serum albumin( BSA) technique which enabled, for 
the first time, quantitation to be introduced into immunocytochemistry. But the 
downside of this technique was that there was excessive shrinkage when 
aldehyde cross-linked BSA was air dried. 
In the 1970s, there was development of two sectioning approaches for the 
localization of intra and extracellular molecules. These approaches involved 
the cryo-section technique or the use of a new generation resins (hydrophilic 
embedding) such as Lowicryl K4M or LR-white. These two techniques led to 
the redundancy of the BSA-embedding technique. Immunocytochemistry is a 
powerful method for antibody localization of proteins in cells/tissues. 
Specificity of results depends on two important criteria: specificity of antibody 
and the method used. The specificity of the antibody used is best determined 
by immunoprecipitation or immunoblot. Specificity of the method used is best 
validated by using controls; negative and positive. The use of controls evolved 
with the use of antibodies in other methods like radioimmunoassay (RIA) and 
enzyme- linked immunosorbent assay (ELISA). Negative control is prepared 
by replacing primary antibody with serum and positive control by using the 
antibody on cells known to contain the protein. 
 In immunocytochemistry, the most common antibody type used is IgG. The 
antibody consists of a variable region and a constant region. The variable 
region (Fab portion) is that part of the antibody that binds to the epitope of the 
antigen and the constant region (Fc portion) is specific to the animal where the 
antibody was raised. In practice, the antibody binding to the antigen of interest 
is called primary antibody and the antibody binding to the Fc portion of 
primary antibody is referred to as secondary antibody. 
There are multiple ways to prepare cell samples for immunocytochemistry. 
Each method has its own unique characteristics so the appropriate method 
should be chosen for the desired sample. 
Cells to be stained could be attached to a support to enable easy handling in 
subsequent procedures. This can be done by different methods: adherent cells 
can be grown on coverslips, microscope slides. Suspension cells could be 
centrifuged onto glass slides or bound to solid support with the help of 
chemical linkers or handled in suspension. 
Concentrated cell suspensions that exist in low-viscosity medium can be made 
into smears. Dilute cell suspensions in a dilute medium are more suited for 
centrifugation onto glass slides. Cell suspensions in high viscosity medium are 
suited for swab preparations. In all these preparations, the whole intact cell 
must be present. For an intercellular reaction to happen, the immunoglobulin 
must first cross the cell membrane that is intact in the above-mentioned 
 preparations. Reactions taking place in nucleus are more difficult. In such 
situations, permeabilization of cells using detergents (Triton X-100 or Tween-
20) or use of organic fixatives (such as acetone, methanol or ethanol) is 
essential.  
A wide range of methods are used in immunocytochemistry where antibodies 
and labels localize proteins in cells. 
The direct method involves use of a detectable tag (such as fluorescent 
molecule, gold particles) directly to antibody which is then allowed to bind to 
the antigen in the cell. Indirect immunocytochemistry which uses an unlabeled 
primary antibody and species-specific labeled secondary antibody is the most 
popular. There are many indirect methods. In one method,  antigen is bound by 
a primary antibody and a secondary antibody is used that binds to the primary 
antibody. To this, a tertiary reagent that contains an enzymatic moiety is added 
that binds to the secondary antibody. When the substrate or quaternary reagent 
is applied, the enzymatic end of tertiary reagent converts substrate into a 
pigmented reaction product. This product produces a colour in the same 
location where the primary antibody recognized the antigen of interest. Some 
examples of substrates used (also referred to as chromogens)  are DAB (3, 3'- 
Diaminobenzidine), AEC (3-Amino-9-EthylCarbazole). When these reagents 
are used after exposure to the required enzyme (such as horseradish 
peroxidase, HRP), there is a positive immunoreaction product.  
 Alternatively, the secondary antibody can be covalently linked to a fluorophore 
(such as FITC and rhodamine) that can be detected using a fluorescence or 
confocal microscope.   
The labeling methods used in immunocytochemistry procedure are grouped 
into three types: enzymes, fluorescence, and particulate. Fluorescence works 
on the principle that light emitted from a fluorophore has a different 
wavelength than the light needed to excite the fluorophore. Histological 
enzymes are those proteins that convert uncoloured water-soluble substrate to 
colored water-insoluble product where HRP is a commonly used enzyme. 
Particulate labels include heavy metals like colloidal gold or gold particles that 
are mainly used for electron microscope immunocytochemistry. 
 
 
Immunocytochemistry Controls 
Primary antibody control is used to confirm specificity and check that primary 
antibody binds to the correct epitope on the antigen. This control also shows 
binding specificity under same conditions as that of the fixed cells or tissue 
section. Thus the primary antibody control shows that the antibody is specific 
for the antigen as well as the effects of fixation and detergent treatment on the 
cells or tissue. 
 The secondary antibody control shows that the labeling is only due to binding 
of secondary antibody to the primary antibody. This is done by either 
eliminating the primary antibody or by replacing it with normal serum from the 
same species. Since there is no primary antibody to bind to secondary 
antibody, no labeling should be seen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Materials and Methods: 
Equipment 
1. Nitrogen Cylinder with liquid nitrogen gas 
2. REMI water bath shaker 
3. Class II Type A2  Biological Safety Cabinet 
4. Thermofisher Series II Water Jacketed CO2 Incubator 
 
Class II biosafety cabinet in our laboratory. 
  
Materials Required 
1. Dulbecco's Modified Eagle's Medium (DMEM):  a bottle containing 
Nutrient mixture F-12 Ham powder with L-glutamine and 15 mM 
HEPES. It was purchased from Sigma (Life Sciences). It was stored at 
 -   C till preparation and used at a concentration of 15.6 grams/litre. 
2. Knockout Serum Replacement: Type- certified, performance plus, 
bought from Gibco (Life Technologies). Quantity- 500 mL that was 
aliquoted into 14 mL fractions and stored at -   C. 
3. L-Glutamine: a bottle containing 25 grams, cell culture tested was 
bought from Sigma (Life Sciences).  
4. Laminin: Mouse laminin isolated from Engelbreth-Holm-Swarm(EHS) 
sarcoma was bought from Gibco. 
5. Monoclonal anti-βIII-Tubulin antibody( neuron):100µl was purchased 
from Sigma. 
6. Mouse embryonic Stem Cells(mESCs): mESC cell line designated R1. 
 
 
 
 
  
Preparation of DMEM 
Procedure 
The working surface of laminar flow hood was decontaminated using 70% 
ethanol. 300 mL of sterile de-ionized water was taken and 1.2 grams of 
NaHCO3 was added to this. The solution was mixed. DMEM powder 
purchased from Sigma (Life Sciences) was added. The solution was mixed 
again between the beaker and the measuring jar. Making up of the solution 
upto 700 mL was done by the addition of de-ionized water. Using 1M NaOH 
solution, pH was adjusted to 7.4. 10 mL Penstrep and 8 mL of Amphotericin 
was then added to the solution. 1mL of ascorbic acid was added and finally, 
the volume was made upto 1 L by the addition of de-ionized water. After 
mixing thoroughly, a sterile filter was placed over a bottle (autoclaved) and 
screwed tight. The vacuum pump was attached at one end and the other end 
was sealed with the stop. The lid was removed and the medium was gently 
poured. The pump was turned on and flow checked. Care was taken to ensure 
prevention of any leaks. Once the medium was filtered, it was aliquoted into 
smaller bottles in order to prevent pH change due to repeated opening. The 
bottles were capped well and labeled. The hood was cleaned and all the waste 
discarded into respective colour coded bins. 
 
 Preparation of mESC Medium 
Requirements 
1. DMEM 
2. Knockout Serum Replacement 
3. Non Essential Amino Acid Solution, 10 mM concentration 
4. L-Glutamine 
Procedure 
The biosafety cabinet was run for 15 minutes to decontaminate the hood. The 
working surface of the laminar hood was decontaminated by spraying 70% 
ethanol. DMEM, Knockout serum replacement and non-essential amino acid 
solution was thawed before use. To prepare 100 mL of mESC medium, 83 mL 
of DMEM was added. To this, 40 milligrams of L-glutamine powder was 
added. 15 mL Knockout serum replacement was thawed and added to the 
solution. Finally, 1 mL of non-essential amino acids was added.  Smaller 
volumes of the medium was  re ared as re uired and stored at  -  C. The 
hood was cleaned and the waste discarded. 
 
 
 
 Thawing and Plating mESCs 
The vial of mESCs was removed from liquid nitrogen storage. The vial was 
rolled between gloved hands until the outside was free of frost. The vial was 
then immersed in a    C water bath without submerging the cap. The vial was 
swirled gently. Simultaneously, the biosafety cabinet was switched on and 
allowed to run for 15 minutes for decontamination.  The vial was removed 
from the water bath when only an ice crystal remained. The vial was sprayed 
with 70% ethanol before taking it into the hood. The cells were then pipetted 
gently into a sterile 50 mL conical tube.  To this, 10 mL of mESC culture 
medium was added slowly dropwise. While adding the medium, the tube was 
gently moved back and forth to mix the mESCs. This was done to reduce the 
osmotic shock to the cells. The vial was then rinsed with 1 mL of mESC 
culture medium and added to the 50 mL conical tube with cells. The cell 
suspension was then transferred to a 15 mL conical tube and centrifuged at 
1100 rpm for 5 minutes. The supernatant was aspirated and the cell pellet was 
resuspended in an appropriate volume of pre-warmed mESC culture medium. 
10µL of the cell suspension was removed and the cell count and viability was 
checked using the Trypan Blue exclusion method. The cell pellet was then 
resuspended in sufficient volume of mESC culture medium by gently pipetting 
the cells up and down in the tube a few times. The cell suspension was then 
added to sterile 35 mm non-treated culture dishes at a plating density of 
approximately 4 Х 10
4 
cells/cm
2 
 
 The culture dishes were then  laced into the    C, 5% CO2 incubator. The 
dishes were moved in several quick figure eight motions to disperse cells 
across the surface of the dishes. The cells were then periodically checked and 
photographed under the microscope. The medium was changed every alternate 
day. One dish was taken for immunocytochemistry to look for expression of 
neuronal marker in day 0 (control) cells. 
 
4-/4+ Protocol 
As per the 4-/4+ RA protocol,  medium supplemented with RA was added on 
the 4th day. Retinoic acid of 0.5 µM concentration was added to the mESC 
medium. The cells were allowed to aggregate into three-dimensional bodies 
called embryoid bodies in suspension medium for 8 days. On the 8th day, 
embryoid bodies were disassociated with trypsin and plated onto adherent 
dishes coated with laminin. 
Laminin coating of culture dishes 
 aminin which was stored at -     was slowly thawed by first  lacing it in   C 
and then brought out to room temperature. The vial was then sprayed with 70% 
ethanol before taking it into the hood. It was diluted using a sterile solution of 
PBS. It was diluted to achieve a final coating concentration of 5µg/cm
2
  and 1 
mL was added to each 35 mm dish. These coated dishes was then placed in a 
 sterile container, sealed tightly and kept at 4  C overnight. After overnight 
refrigeration, these dishes  were then taken into the laminar airflow hood and 
the excess laminin was aspirated. The cell suspension containing embryoid 
bodies was then disassociated with trypsin and then transferred to these 
laminin coated dishes. 
The medium was changed every alternate day and the dishes were inspected 
regularly and photographed. When sufficient cells with neuronal morphology 
were observed, expression of neuronal markers was checked using 
immunocytochemistry. 
 
 
 
 
 
 
 
 
 
 Immunocytochemistry 
The cells were fixed with 4% paraformaldehyde for 15 to 20 minutes. They 
were washed with PBS thrice (When done on day 0 cells that were in 
suspension, washing was done by centrifugation).  The cells were then 
permeabilized and blocked with blocking solution for 1 hour. The composition 
of the blocking solution was 1% BSA+6% FBS+ 0.1%TritonX100 in PBS. 
Primary antibody was added and incubated for 1 hour. Cells were washed 
thrice with permeabilizing and blocking solution. The composition of this 
solution was 0.1% BSA+ 6%FBS+ 0.1%TritonX100 in PBS. The secondary 
antibody was then added and incubated for 1 hour. Cells were washed with 
PBS thrice.  They were then counterstained with DAPI for 5 minutes and 
washed twice with PBS.  Imaging was done using a fluorescence microscope 
(DMI6000B, Leica Microsystems, Wetzlar, Germany) with appropriate filters. 
Primary antibody used was monoclonal anti-βIII-Tubulin antibody( T8578, 
Sigma) and secondary antibodies were anti-mouse or anti-rabbit IgGs 
conjugated with Alexa Fluor 488 ( 11029, Life technologies).  All antibodies 
were used at dilutions recommended by manufacturers.  
For Unstained Control:  The aforementioned procedure was followed with the 
exception that both primary and secondary antibodies were not added. DAPI 
was added to stain the nuclei. This was done to check for autofluorescence. 
 Secondary Antibody Control: Here the primary antibody was not added. This 
was done to check for specificity of the antibody. 
 
 
 
 
 
 
 
 
 
 
 
 
 Results 
Day 0 : mESCs stored in liquid nitrogen was thawed and plated on non-treated 
dishes. These cells belonged to passage 7 of R1 cell line. (Figures 1, 2 and 3) 
Figure 1:  Appearance of day 0 mESCs 
 
 
 
 
 
 
  
 
 
Figure 2: Day 0 mESCS  
 
 
 
 
 
  
Day 1: Within few hours of plating in a suspension culture, cells began to 
aggregate. The ESCs did not attach to the surface and formed small floating 
aggregates. (Figure 4) 
 
 
 Figure 4:  Day 1 cells: Cells aggregating to form an embryoid body.  
 
 
 
 Day 3: Most cells have aggregated to form clusters of embyroid bodies. They 
have not achieved a perfectly spherical shape and the clusters show irregular 
outlines. Single cells were seen floating around mostly as debris. (Figure 5)
 
Figure 5:  Day 3 cells showing formation of embryoid body.  
 
 
 
 
 
 Day 4:  Medium supplemented with retinoic acid was added to the culture 
dishes. The embryoid bodies that had formed were not uniform in size and 
shape. (Figure 6) 
 
Figure 6:  Day 4 embryoid bodies of irregular shape and size. 
 
Day 5 - 7: No significant changes were observed. 
Day 8: The embryoid bodies were disassociated with trypsin and plated on 
laminin coated dishes.  
 
 
 Day 9: Flat cells that were just beginning to give out processes were faintly 
seen, giving a morphology of neuronal precursor cells. (Figure 7 and 8) 
 
Figure 7: Day 9 cells showing emergence of flat cells. 
 
Figure 8: Day 9 cells, magnified. 
 Day 10: Extremely flat cells with long, slender processes were seen
 
Figure 9:  Day 10 cells, solid arrow shows long, slender processes. 
 
Figure 10: Day 10 cells showing emergence of flat cells with processes 
branching out from embryoid bodies  
 Day 11: No significant progress was noted from the previous day. (Figures 11 
and 12) 
 
Figure 11:  Day 11 cells 
 
Figure 12:  Day 11 cells showing neuronal precursor like morphology 
 Day 12: Neuron-like cells having small cell bodies were observed.  
 
Figure 13:  Day 12 cells 
Day 13: Number of cells with neuronal morphology has significantly 
increased. (Figure 14) 
 
Figure 14: Day 13 cells  
  
 
Day 14:  Halo of neurites emanating from an embryoid body was seen. 
Neuritic outgrowths occur at many points along the perimeter of the aggregate. 
(Figure 15) 
 
Figure 15: Day 14 cells   
 
 
 
 
  
 
Day 15: Dense, tangled collection of neurites, progressively increasing in 
number was seen. (Figure 16) 
 
Figure 16: Day 15 cells 
 
 
 
 
 Day 16: Neuritic outgrowth progressing to higher complexity. 
 
Figure 17: Day 16 cells 
 
Figure 18: Day 16 cells 
 Day 17: The tangle exhibits extensive neuronal differentiation.  
 
Figure 19: Day 17 cells 
 
Figure 20: Day 17 cells 
 Day 18: The cells formed a confluent monolayer of neuron-like cells.  
 
Figure 21: Day 18 cells  
 
Figure 22: Day 18 cells 
 Immunofluorescence 
Day 0: Unstained control was performed on day 0 cells. (Figure 23) 
Day 0: Staining was done with βIII-Tubulin and did not show any fluorescence 
indicating that Day 0 cells did not express this marker which is specific for 
neurons. (Figures  25 and 26) 
 
 
Figure 23: Unstained Control: Without  primary and secondary antibody 
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Figure 24:  Secondary Antibody Control.                                                  
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Figure 25 : Day 0 Cells stained with βIII-Tubulin (β III Tub) . 
A. Nuclei counterstained with DAPI(blue); B.Cells stained with βIII-
Tubulin(green) 
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Figure 26:  Day 0 cells stained with βIII-Tubulin 
A. Nuclei counterstained with DAPI(blue); B.Cells stained with βIII-
Tubulin(green) 
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 Day 3: Embryoid bodies stained with βIII-Tubulin did not stain positive. 
 
 
 
Figure 27: Day 3 embryoid body 
A. Nuclei counterstained with DAPI(blue); B.Cells stained with βIII-
Tubulin(green) 
A DAPI B βIII Tubb 
C Merge 
 Day 5: Embryoid body stained with βIII-Tubulin shows faint fluorescence 
showing that retinoic acid begins to exert its influence within a day.  
 
     
 
Figure 28:  Day 5 embryoid body stained with βIII-Tubulin 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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 Day 7: Embryoid body stained with βIII-Tubulin. The embryoid body almost 
entirely stained positive showing that almost all cells within the embryoid 
body were differentiating towards neural lineage.  
 
 
Figure 29:  Day 7 embryoid body stained with βIII-Tubulin 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
A  B DAPI β III Tub 
C Merge 
 Day 8: Embryoid bodies stained with βIII-Tubulin were strongly positive for 
the marker indicating that by day 8 retinoic acid had converted most of the 
cells into neuronal cells.  
 
 
 
Figure 30:  Day 8 embryoid bodies stained with βIII-Tubulin 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
A DAPI   B β III Tub 
C Merge 
 Day 10: Neural cells emerging from embryoid body  seen when plated on 
laminin coated dishes. Both the embryoid bodies and the cells expressed βIII-
Tubulin.  
 
 
Figure 31: Neuronal cells( expressing βIII-Tubulin antibody) emerging from 
an embryoid body on day 10   
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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 Day 12: Spindle shaped cells were observed that stained positive for βIII-
Tubulin.  
     
 
 
Figure 32: Day 12 cells expressing βIII-Tubulin and having neurites 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
A DAPI B β III Tub 
C Merge 
 Day 14: Confluence of cells expressing βIII-Tubulin was observed. Certain 
fields showed cells exhibiting typical neural morphology.  
 
 
 
Figure 33: Day 14 cell showing positive staining for βIII-Tubulin and having 
neuronal morphology. 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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Figure 34: Day 14 cell showing neuronal outgrowths 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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Figure 35: Day 14 at 40X magnification 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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Figure 36: Day 14 showing confluence of cells expressing βIII-Tubulin. 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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Figure 37: Day 14 cells 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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Figure 38:  Day 14 cells. 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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Figure 39:  Day 14 cell. 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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 Day 20: An extensive tangled network of neurons observed. (Figure 40). 
              
 
Figure 40: Day 20 cells showing an extensive network of neurons 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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Figure 41: An undisassociated embryoid body almost completely expressing 
the neuronal marker (βIII-Tubulin) on day 20. 
A. Nuclei counterstained with DAPI(blue); B. Staining with βIII-
Tubulin(green) indicating neurons. 
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 Discussion 
 
ESCs by virtue of the combination of their two unique properties- pluripotency 
and self-renewal have garnered intense interest in the field of biological 
sciences. The promising property of "being able to differentiate into any cell 
type" makes it a tool that can be used to not only harness cell types but also 
find application in replacement and regeneration. The availability and ease 
with which it can be cultured and studied in vitro have also helped further 
knowledge about these cells. 
Because neurons are a cell population that do not regrow or regenerate once 
damaged, the neural differentiation of  ESCs has potentially large implications 
in transplantation for neurodegenerative diseases and neural damage. Though 
several different protocols have been established and studied to generate 
neurons from ESCs, there is still a need to study and corroborate these findings 
largely because of the complex heterogeneity of the cells obtained. Also, it is 
highly imperative that pure populations of  neurons be produced with complete 
elimination of ESCs for tissue transplantation because ESCs can generate 
teratocarcinomas.  
This study was aimed at testing a culture protocol converting mESCs to 
neurons using retinoic acid. All-trans retinoic acid has been found to play a 
critical role in central nervous system morphogenesis, differentiation and 
 conferring cell-type specificity. While there are other protocols for neural 
differentiation involving molecules like noggin, Shh (Sonic Hedgehog  
protein) and FGF, we chose to test this protocol because retinoic acid is more 
cost effective, easily available and said to play a larger role in neural 
development. 
This protocol, referred to as the 4-/4+ protocol, involves spontaneous 
differentiation of mESCs into embryoid bodies in suspension culture for 4 days 
and addition of 0.5 µM RA on the 4th day. The cells were allowed to aggregate 
in the presence of RA for another four days and then plated on laminin-coated 
dishes on the 8th day. They were plated both as intact aggregates and post-
disassociation with trypsin. In both cases, it was found that they gave out flat 
cells tightly adherent to the surface with an initial spindle shaped bipolar 
morphology that gradually progressed to pyramidal shaped cells with multiple 
neurites. As guided by previous studies, a 0.5 µM concentration of RA was 
chosen as the most appropriate concentration for neuronal differentiation. 
Laminin was used as a substrate to coat the culture dishes as it facilitated good 
attachment of cells. When cells were plated on treated culture dishes that were 
not coated with laminin, it resulted in poor attachment and eventually cell 
death. While there are other adhesion substrates available to coat culture dishes 
for better attachment like fibronectin , poly-L-lysine and collagen, laminin was 
chosen because it has been proven to play a role in neurogenesis as promoter 
of neuritic outgrowth and selective adhesion. 
 Phenotypically,  the cells obtained by this culture protocol resembled neurons. 
Immunocytochemistry was used to confirm the presence of neurons by using a 
neuron specific isoform of monoclonal βIII-Tubulin. When day 0 cells, that 
had just been thawed and plated, were stained with this marker, they did not 
fluoresce. Day 3 embryoid body (before addition of RA) too did not stain 
positive for the marker. By day 6, embryoid bodies (after addition of RA on 
day 4) showed fluorescence with βIII-Tubulin, indicating that the addition of 
RA nudges the cells towards neuronal differentiation. Days that followed 
showed remarkable, exponential growth of neuron-like cells of increasing 
complexity. By day 18, the cells reached a confluent monolayer with most of 
the cells staining positive for βIII-Tubulin. On day 20, an extensive network of 
tangled neural connections could be observed using immunocytochemistry. 
Hence, this culture protocol can be used to successfully convert mESCs to 
neurons. 
While the primary objective in the culture of ESCs is to generate the cell line 
of interest, it also serves as a powerful tool to study mammalian development. 
Due to the similarities between embryoid bodies and pre-gastrulation embryo, 
the method of spontaneous differentiation is extensively used to examine the 
effect of cell signaling pathways and effects of various chemicals during 
embryogenesis. In this study too, the morphological course of progression of 
an embryoid body to flat spindle shaped cells and finally to mature pyramidal 
 shaped neurons can be appreciated. This allows a peek into the mysterious and 
complex process of development taking place in vivo. 
 
 
 
 
 
 
   
 
 
 
 
 
 
 Limitations 
 
Only a single marker, i.e., βIII-Tubulin was used in the study. Other markers 
such as klf4, sox2 and nanog to check for pluripotency and GFAP (Glial 
Fibrillary Acidic Protein) to check for glial cells could have been used to make 
the study more comprehensive.  
 
 
 
 
 
 
 
 
      
   Conclusion 
      
       Mouse embryonic stem cells  placed in suspension culture formed 
aggregates called embryoid bodies. This when exposed to retinoic acid 
differentiated into cells phenotypically resembling neurons. These neuron-
like cells expressed βIII-Tubulin which is a marker for neurons . Thus RA 
induces differentiation of stem cells into neurons.   
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